Rajeev Saggar
Directeur Technique/Scientifique/R&D chez LIQUIDIA CORPORATION
Fortune : 3 M $ au 30/04/2024
Postes actifs de Rajeev Saggar
Sociétés | Poste | Début | Fin |
---|---|---|---|
LIQUIDIA CORPORATION | Directeur Technique/Scientifique/R&D | 18/07/2022 | - |
Historique de carrière de Rajeev Saggar
Anciens postes connus de Rajeev Saggar
Sociétés | Poste | Début | Fin |
---|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/09/2021 | 01/07/2022 |
The Banner-University Medical Center | Corporate Officer/Principal | - | - |
Formation de Rajeev Saggar
University of California, Irvine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
LIQUIDIA CORPORATION | Health Technology |
Entreprise privées | 1 |
---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
- Bourse
- Insiders
- Rajeev Saggar
- Expérience